TLC and IR detection of sildenafil as an undeclared adulterant in some herbal aphrodisiac products marketed in northwest Nigeria

Main Article Content

Aminu T. Lawal
Aminu Musa
Musa A. Usman

Abstract

Background: Sildenafil, a phosphodiestrate-5 (PDE-5) inhibitor is used in the treatment of erectile dysfunction. There have been reports of adulteration of herbal products with PDE-5 inhibitors without considering its deleterious consequences to public safety.


Objectives: To evaluate the presence of sildenafil as an undeclared adulterant in herbal products marketed in northwest Nigeria by TLC/IR Spectroscopy.


Methods: A survey of herbal aphrodisiac products marketed in four Northwestern Nigerian states was carried out. A sample size (50) representative of the total products surveyed was collected for this study. A simple, rapid thin layer chromatographic (TLC) method was employed for the identification of sildenafil adulterant in herbal aphrodisiac samples. Presence of sildenafil from the suspected products was confirmed by Fourier transform Infrared (FTIR) analysis.


Results: TLC method revealed 16 out of 50 herbal aphrodisiac samples to contain sildenafil which was affirmed by Infrared spectroscopy.


Conclusion: About 32% of the market products sampled were adulterated with sildenafil. The use of such products poses a serious threat to public safety.

Downloads

Download data is not yet available.

Article Details

How to Cite
Lawal, A. T., Musa, A., & Usman, M. A. (2023). TLC and IR detection of sildenafil as an undeclared adulterant in some herbal aphrodisiac products marketed in northwest Nigeria. West African Journal of Pharmacy, 31(1), 119 – 128. https://doi.org/10.60787/wapcp-31-1-211
Section
Articles

How to Cite

Lawal, A. T., Musa, A., & Usman, M. A. (2023). TLC and IR detection of sildenafil as an undeclared adulterant in some herbal aphrodisiac products marketed in northwest Nigeria. West African Journal of Pharmacy, 31(1), 119 – 128. https://doi.org/10.60787/wapcp-31-1-211

Share

References

American Society of Health-System Pharmacists (2018). "Sildenafil citrate” Retrieve from https://www.drugs.com/monograph/sildenafilcitrate.html

Vitezic D (2001). A risk-benefit assessment of sildenafil in the treatment of erectile dysfunction. Drug Safety, 24: 255–265

Padma-nathan H, Eardly I, Kloner RA, Laties MC, Montorsi F (2002). A 4-year update on the safety of Sildenafil citrate (Viagra). Urology, 60: 67–90

Bello M(2009).Adolescent Health and information project. Sahara Reporters, Jun 13

Paul G, Gibbs RSJ, Boobis AR, Abbas A, Wilkins MR(2005)Bosentan decreases the plasma concentration of sildenafil when co prescribed in

pulmonary hypertension. British Journal of Clinical Pharmacology, 60:107–112.

World Health Organization (2005): National Policy on Traditional Medicine and Regulation of Herbal Medicines- Report of a WHO global survey

Gatz SR, Cheryl L F, Karen AW(2004). Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal

matrices by LC-ESI-MS and LC-UV. Journal of Pharmaceutical and Biomedical Analysis, 36: 525 – 533

Taher A, Setiawati A(2013). Victory project: a study of counterfeit PDE5 inhibitor (sildenafil) in Indonesia. Acta MedicaIndonesiana, 45: 290-294

Shantier SW, Saeed SMA, Mohamed MA, Gadkariem EA, Ismail EMO (2015). Determination of undeclared sildenafil citrate and tadalafil in

aphrodisiac herbal preparations by TLC and HPLC. International journal of Innovation of Pharmaceutical Sciences and Research 3:688-669

Feenstra J, Van Drei-pierik R, Lacle C, Stricker B(1998). Acute myocardial infarction associated with Sildenafil.Lancet, 352: 957–958.

Kekilli M, Beyazit Y, Purnak T, Dogon S,Atalar E (2005). Acute myocardial infarction after Sildenafil citrate ingestion. Annals of Pharmacothery,39: 1362–1364.

Silverstein RM, Bassler GC, Morrill TC (1981). Spectrometric Identification of Organic Compounds.4th Ed. New York: John Wiley and Sons.

QD272, S6- S5

Caprez S, Hamburger M, Reich E, Schibli A (2005). Development of methods for analysis of synthetic adulterants in herbal medicines by HPLC. Camagchemieerzeugnisse und adsorption stechnikag

Peter M, Pedro PC, Alexandre C, Mauricio C, Wellington RG (2003). Physicochemical properties of sildenafil citrate (Viagra) and sildenafil base. Journal of pharmaceutical sciences, 92: 2140-2143

Pavia DL, Lampman GM, Kriz, GS (2001). Introduction to Spectroscopy, Thomson Learning Inc, USA.

Yathirajan HS, Nagaraj B, Nagaraja P, Bolte M (2005). Silden afilcitrate monohydrate. Acta Crystallographica, 61: 489–491

Vredenbregt MJ (2006). Screening suspected counterfeit Viagra